NCT00006518
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Recruiting
Not specifiedAges 18+ObservationalNational Cancer Institute (NCI)Government-funded
~1,029 participants
Updated 2026-08-31 on ClinicalTrials.gov
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acquisition of serum, circulating cells, bone marrow, and tumor or normal tissue samples from participants with HIV infection, KSHV infection, or with cancer.
Measured over Ongoing
Conditions
Where it's being run
1 sites across 1 statesMaryland1
Study leadership
- Robert Yarchoan, M.D. · PRINCIPAL_INVESTIGATOR · National Cancer Institute (NCI)
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age 18 years or older.
ECOG performance status less than or equal to 3
Exposure risk to HIV, KSHV, or HPV
HIV seropositive
KSHV seropositive
EBV seropositive
HTLV-1 seropositive
Malignancy, MCD, or skin lesions with appearance of KS
Cervical or anal intraepithelial lesion
Ability of participant to understand and the willingness to sign a written informed consent document.
What this trial measures
- Acquisition of serum, circulating cells, bone marrow, and tumor or normal tissue samples from participants with HIV infection, KSHV infection, or with cancer.Ongoing
Proportion of participants that have contributed serum, circulating cells, bone marrow, and tumor or normal tissue samples